25.43

0.14% -0.17

Stevanato Group Spa (STVN)

Overview News Price History Option Chain Why STVN Down? Discussions Forecast Dividend History

Stevanato Group Spa stock is traded at $25.43, with a volume of 8,170. It is down -0.14% in the last 24 hours and up +2.38% over the past month. Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

Previous Close:

$25.26

Open:

$25.29

24h Volume:

8,170

Relative Volume:

0.03

Market Cap:

$6.72B

Revenue:

$1.19B

Net Income/Loss:

$124.38M

P/E Ratio:

54.55

EPS:

0.4662

Net Cash Flow:

$-678.26M

1W Performance:

+2.59%

1M Performance:

+2.38%

6M Performance:

+9.96%

1Y Performance:

+28.31%

1-Day Range:

$24.93

$25.85

1-Week Range:

$23.64

$25.85

52-Week Range:

$17.12

$25.88

Stevanato Group Spa Stock (STVN) Company Profile

Name

Stevanato Group Spa

Sector

Healthcare (1165)

Industry

Medical Instruments & Supplies (60)

Phone

Address

Employee

5,521

Twitter

Next Earnings Date

2024-11-05

Latest SEC Filings

STVN's Discussions on Twitter

Compare STVN with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
STVN Stevanato Group Spa	25.45	6.72B	1.19B	124.38M	-678.26M	0.4662
ISRG Intuitive Surgical Inc	522.32	189.82B	8.71B	2.48B	1.75B	6.82
BDX Becton Dickinson Co	175.54	49.98B	20.87B	1.50B	2.59B	5.24
ALC Alcon Inc	87.80	44.00B	9.93B	1.12B	1.58B	2.25
RMD Resmed Inc	257.26	37.05B	5.02B	1.31B	1.56B	8.91
WST West Pharmaceutical Services Inc	227.49	16.36B	2.90B	467.20M	306.90M	6.37

Stevanato Group Spa Stock (STVN) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-13-24	Initiated	Wolfe Research	Outperform
Dec-03-24	Resumed	Morgan Stanley	Equal-Weight
Apr-22-24	Initiated	Exane BNP Paribas	Outperform
Nov-01-23	Downgrade	Jefferies	Buy → Hold
Sep-26-23	Initiated	Stephens	Overweight
Sep-19-23	Initiated	CJS Securities	Market Outperform
Aug-24-23	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Aug-10-21	Initiated	BofA Securities	Buy
Aug-10-21	Initiated	Citigroup	Buy
Aug-10-21	Initiated	Jefferies	Buy
Aug-10-21	Initiated	KeyBanc Capital Markets	Overweight
Aug-10-21	Initiated	Morgan Stanley	Overweight
Aug-10-21	Initiated	Wells Fargo	Overweight

View All

Stevanato Group Spa Stock (STVN) Latest News

Jun 17, 2025

Stevanato Group S.p.A. (NYSE:STVN) Stock Position Lifted by Conestoga Capital Advisors LLC - MarketBeat

Jun 17, 2025

Yarbrough Capital LLC Buys New Position in Stevanato Group S.p.A. (NYSE:STVN) - MarketBeat

Jun 11, 2025

Pharmaceutical Visual Inspection Systems Market Trends | - openPR.com

Jun 11, 2025

Jun 10, 2025